Terms: = Leukemia AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Staging
7 results:
1. Elevated levels of circulatory follicular T helper cells in chronic lymphocytic leukemia contribute to B cell expansion.
Le Saos-Patrinos C; Loizon S; Zouine A; Turpin D; Dilhuydy MS; Blanco P; Sisirak V; Forcade E; Duluc D
J Leukoc Biol; 2023 Mar; 113(3):305-314. PubMed ID: 36807447
[TBL] [Abstract] [Full Text] [Related]
2. Plasma soluble programmed death ligand 1 levels predict clinical response in peripheral T-cell lymphomas.
Zhang X; Liu L; Zhou S; Zhao K; Song Z; Hu G; Zhang T; Li Y; Qiu L; Li L; Qian Z; Meng B; Pan Y; Ren X; Wang X; Zhang H; Fu K
Hematol Oncol; 2019 Aug; 37(3):270-276. PubMed ID: 31074879
[TBL] [Abstract] [Full Text] [Related]
3. CD4+ T Cells are Exhausted and Show Functional Defects in Chronic Lymphocytic leukemia.
Allahmoradi E; Taghiloo S; Tehrani M; Hossein-Nattaj H; Janbabaei G; Shekarriz R; Asgarian-Omran H
Iran J Immunol; 2017 Dec; 14(4):257-269. PubMed ID: 29276179
[TBL] [Abstract] [Full Text] [Related]
4. Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies.
Khan M; Siddiqi R; Thompson PA
Ann Hematol; 2018 Jan; 97(1):1-15. PubMed ID: 29063177
[TBL] [Abstract] [Full Text] [Related]
5. [pd-1/PD-L1 expression and its implications in patients with chronic lymphocytic leukemia].
Li JH; Pang NN; Zhang ZH; Zhang R; Chen G; Qu JH
Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):198-203. PubMed ID: 28395442
[No Abstract] [Full Text] [Related]
6. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
Agostinelli C; Gallamini A; Stracqualursi L; Agati P; Tripodo C; Fuligni F; Sista MT; Fanti S; Biggi A; Vitolo U; Rigacci L; Merli F; Patti C; Romano A; Levis A; Trentin L; Stelitano C; Borra A; Piccaluga PP; Hamilton-Dutoit S; Kamper P; Zaucha JM; Małkowski B; Kulikowski W; Tajer J; Subocz E; Rybka J; Steidl C; Broccoli A; Argnani L; Gascoyne RD; d'Amore F; Zinzani PL; Pileri SA
Lancet Haematol; 2016 Oct; 3(10):e467-e479. PubMed ID: 27692305
[TBL] [Abstract] [Full Text] [Related]
7. Utility of cd279/pd-1 immunohistochemistry in the evaluation of benign and neoplastic T-cell-rich bone marrow infiltrates.
Cogbill CH; Swerdlow SH; Gibson SE
Am J Clin Pathol; 2014 Jul; 142(1):88-98. PubMed ID: 24926091
[TBL] [Abstract] [Full Text] [Related]
